Cytosorbents Corporation (NASDAQ:CTSO) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Catherine, and I will be your conference operator today.
Cytosorbents Corp (CTSO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Skylands Capital Charles Paquelet | 2,755,427 | $4,133,141 | -4% | 0.56% |
| 2. | Renaissance Technologies Jim Simons | 79,620 | $119,430 | +6% | 0% |
| 3. | Citadel Investment Group Ken Griffin | 29,087 | $43,631 | 0% | |
| 4. | 15,400 | $23,100 | +53% | 0% | |
| 5. | Millennium Management Israel Englander | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.96 | 20,000 | Officer | 401,363 | 2024-12-13 | Filing | |
| $0.89 | 20,000 | Officer | 381,363 | 2024-12-12 | Filing | |
| $0.89 | 11,363 | Officer | 361,363 | 2024-12-11 | Filing | |
| $1.33 | 22,557 | Director | 101,857 | 2023-12-13 | Filing | |
| $1.33 | 22,557 | Officer | 348,433 | 2023-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.40 | 4,000 | Director | 125,046 | 2021-08-31 | Filing | |
| $8.00 | 8,000 | Director | 125,046 | 2020-11-10 | Filing | |
| $10.00 | 10,000 | Officer | 417,649 | 2020-04-27 | Filing | |
| $6.00 | 4,677 | Officer | 417,649 | 2020-03-10 | Filing | |
| $9.37 | 24,337 | Officer, Director | 503,281 | 2018-12-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,618,143 | $4,016,139 | 0.13% | |
| 2. | 3,051,402 | $3,387,056 | 0.29% | |
| 3. | 1,949,551 | $2,164,001 | 0% | |
| 4. | 1,801,799 | $1,996,581 | 0% | |
| 5. | 1,308,747 | $1,452,709 | 0.31% |
News See All
Cytosorbents Corporation (NASDAQ:CTSO) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, good afternoon, and welcome to the CytoSorbents Second Quarter 2024 Financial and Operating Results Conference Call.
Cytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call Transcript
Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.11717, expectations were $-0.12.
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the CytoSorbents’ Fourth Quarter and Full-Year 2023 Financial and Operating Results Conference Call.
Cytosorbents Corporation (NASDAQ:CTSO) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to CytoSorbents third quarter 2023 financial and operating results conference call. [Operator Instructions].
Cytosorbents Corporation (NASDAQ:CTSO) Q1 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Cytosorbents First Quarter 2023 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Cytosorbents Fourth Quarter and Full Year 2022 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Is CTSO A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Hedge Funds Have Never Been More Bullish On Cytosorbents Corp (CTSO)
In this article we will take a look at whether hedge funds think Cytosorbents Corp (NASDAQ:CTSO) is a good investment right now.
Is Cytosorbents Corporation (CTSO) A Good Stock To Buy?
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.